Caring for a Three Legged Dog or Cat
Tripawds is the place to learn how to care for a three legged dog or cat, with answers about dog leg amputation, and cat amputation recovery from many years of member experiences.
JUMP TO FORUMS ↓
Join The Tripawds Community
Learn how to help three legged dogs and cats in the forums below. Browse and search as a guest or register for free and get full member benefits:
What does it mean to Be More Dog?
Find out in Be More Dog: Learning to Live in the Now by Tripawds founders Rene and Jim. Learn life lessons learned from their Chief Fun Officer Jerry G. Dawg! Get the book and find fun gifts in the Be More Dog Bookstore.
Super duper exciting news from our friends at ELIAS, for dogs with osteosarcoma. For background info see:
Here's the great news from the company's 12 November 2020 press release)
OLATHE, Kan., Nov. 12, 2020 /PRNewswire/ -- ELIAS Animal Health, a clinical stage development company advancing novel treatments for cancer in companion animals, announces that 10 investigation sites across the U.S. are now participating in the pivotal trial of ELIAS cancer immunotherapy (ECI®). This marks an expansion of the study ELIAS initiated in May to pursue licensure of ECI treatment combined with surgery as an alternative to chemotherapy for dogs diagnosed with osteosarcoma, a deadly form of bone cancer.
The geographical areas served by the clinical trial investigation sites include
- Southern California
- the Intermountain Region
- the Desert Southwest
- the Chicago metropolitan area
- North Texas
- the Carolinas
- and the Mid-Atlantic region, which includes Southeast Pennsylvania, Virginia and Washington, D.C.
ELIAS will continue recruiting sites to further expand pet owner access to the trial. To learn more about participating sites and patient eligibility, visit http://www.elia.....eci-osa-04.
The clinical trial's objective is to evaluate the efficacy and safety of ECI compared to the current standard of care carboplatin chemotherapy. ECI is a form of immunotherapy that involves treating the patient with its own cancer-specific "killer" T cells. Following surgery, patients will be randomized into two cohorts which will receive either the experimental immunotherapy or chemotherapy. ELIAS will study data from the clinical trial along with data provided by 25 veterinary hospitals offering ECI to canine osteosarcoma patients under 9 CFR 103.3 as an experimental product.
"As we continue expanding the trial, we are excited to evaluate our personalized approach to treating canine osteosarcoma in a larger population of dogs," said Tammie Wahaus, chief executive officer, ELIAS Animal Health.
Veterinarians interested in more information on the clinical program may visit http://www.elia.....health.com or contact ELIAS at firstname.lastname@example.org. Interested investors may contact ELIAS at email@example.com.
Thanks Rene! It's especially encouraging to know that locations have been expanded where these trials can take place. Hope for good news to continue on this project
Happy Hannah had a glorious additional bonus time of over one yr & two months after amp for osteo! She made me laugh everyday! Joined April's Angels after send off meal of steak, ice cream, M&Ms & deer poop!
Yeah I was glad to see that. Immunotherapy is working for so many pets with cancer, I'm happy to know that it's getting out there for more of them.
16 October 2012
This is great news. Glad of expanded testing areas as well.
Sassy is a proud member of the Winter Warriors. Live long, & strong Winter Warriors.
07/26/2006 - Sassy earned her wings 08/20/2013
05/04/2006 - Bosch, Sassy's pal, earned his wings 03/29/19 fought cancer for 4 months.
"You aren't doing it TO her, you are doing it FOR her. Give her a chance at life."
This just infrom Tiny's people, who are enrolled in the following:
ELIAS is partnering with several vet clinics for the following clinical trial for dogs with osteosarcoma:
- Trial enrollment is required prior to amputation (affected limb must be intact)
- Treatment includes either ECI immunotherapy or carboplatin chemotherapy
- Patients must complete a 7-11 week treatment regimen and return for quarterly follow-up visits throughout the 18-month trial
- Study sponsor will cover treatment costs (including consult with oncologist, radiographs, lab work, ECI immunotherapy or carboplatin chemotherapy treatment, and their administration)
Check out the link for information about qualifying and where to go for more info.